Citadel Advisors
REUN

Citadel Advisors’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Citadel Advisors’s Portfolio REUN Stock Details REUN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,140
Closed -$9K – 13994
2022
Q2 		$9K Buy
+2,140
New +$10.7K ﹤0.01% 12618

Other funds holding REUN

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
OPOWM
One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.27B AUM 19.34% 1-Year Est. Return

Citadel Advisors's REUN Position: Q3 2022 in Review

Citadel Advisors sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2022, closing a stake of 6,206 shares — an estimated $26K sold.

Citadel Advisors first reported a position in REUN in Q3 2021 and held it in 4 quarters. The position peaked at $117K in Q4 2021. 27 funds tracked by Wall St. Rank hold REUN as of Q3 2022.

  • Citadel Advisors reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 6,206 Reunion Neuroscience Inc. Common Shares shares in Q3 2022, an estimated $26K.
  • Citadel Advisors first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 4 quarters.
  • Citadel Advisors's Reunion Neuroscience Inc. Common Shares position peaked at $117K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.